Buckingham Research Downgrades Endo Health (ENDP) to Neutral
Tweet Send to a Friend
Buckingham Research downgraded Endo Health (NASDAQ: ENDP) from Buy to Neutral.
This article: 59 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 59 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
